Literature DB >> 25422082

Comprehensive characterization of the genomic alterations in human gastric cancer.

Juan Cui1, Yanbin Yin, Qin Ma, Guoqing Wang, Victor Olman, Yu Zhang, Wen-Chi Chou, Celine S Hong, Chi Zhang, Sha Cao, Xizeng Mao, Ying Li, Steve Qin, Shaying Zhao, Jing Jiang, Phil Hastings, Fan Li, Ying Xu.   

Abstract

Gastric cancer is one of the most prevalent and aggressive cancers worldwide, and its molecular mechanism remains largely elusive. Here we report the genomic landscape in primary gastric adenocarcinoma of human, based on the complete genome sequences of five pairs of cancer and matching normal samples. In total, 103,464 somatic point mutations, including 407 nonsynonymous ones, were identified and the most recurrent mutations were harbored by Mucins (MUC3A and MUC12) and transcription factors (ZNF717, ZNF595 and TP53). 679 genomic rearrangements were detected, which affect 355 protein-coding genes; and 76 genes show copy number changes. Through mapping the boundaries of the rearranged regions to the folded three-dimensional structure of human chromosomes, we determined that 79.6% of the chromosomal rearrangements happen among DNA fragments in close spatial proximity, especially when two endpoints stay in a similar replication phase. We demonstrated evidences that microhomology-mediated break-induced replication was utilized as a mechanism in inducing ∼40.9% of the identified genomic changes in gastric tumor. Our data analyses revealed potential integrations of Helicobacter pylori DNA into the gastric cancer genomes. Overall a large set of novel genomic variations were detected in these gastric cancer genomes, which may be essential to the study of the genetic basis and molecular mechanism of the gastric tumorigenesis.
© 2014 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.

Entities:  

Keywords:  bioinformatics; cancer mutations; gastric cancer; genomic variations; next-generation sequencing

Mesh:

Substances:

Year:  2014        PMID: 25422082      PMCID: PMC4776643          DOI: 10.1002/ijc.29352

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Helicobacter pylori causes DNA damage in gastric epithelial cells.

Authors:  B Obst; S Wagner; K F Sewing; W Beil
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

3.  A novel zinc finger protein, ZZaPK, interacts with ZAK and stimulates the ZAK-expressing cells re-entering the cell cycle.

Authors:  Jaw-Ji Yang
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

Review 4.  Common fragile sites.

Authors:  Thomas W Glover
Journal:  Cancer Lett       Date:  2005-10-17       Impact factor: 8.679

5.  Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.

Authors:  C Y Muller; J D O'Boyle; K M Fong; I I Wistuba; E Biesterveld; M Ahmadian; D S Miller; A F Gazdar; J D Minna
Journal:  J Natl Cancer Inst       Date:  1998-03-18       Impact factor: 13.506

6.  Fhit is a physiological target of the protein kinase Src.

Authors:  Yuri Pekarsky; Preston N Garrison; Alexey Palamarchuk; Nicola Zanesi; Rami I Aqeilan; Kay Huebner; Larry D Barnes; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

7.  Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins.

Authors:  Sara Lindén; Jafar Mahdavi; Jan Hedenbro; Thomas Borén; Ingemar Carlstedt
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

8.  JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.

Authors:  Nan-Shan Chang; Joan Doherty; Amy Ensign
Journal:  J Biol Chem       Date:  2003-01-06       Impact factor: 5.157

9.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

10.  The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website.

Authors:  S Bamford; E Dawson; S Forbes; J Clements; R Pettett; A Dogan; A Flanagan; J Teague; P A Futreal; M R Stratton; R Wooster
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

View more
  32 in total

Review 1.  Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer.

Authors:  Beate Rau; Andreas Brandl; Andreas Pascher; Wieland Raue; Paul Sugarbaker
Journal:  Visc Med       Date:  2017-02-10

2.  Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Authors:  Malin Lando; Christina S Fjeldbo; Saskia M Wilting; Barbara C Snoek; Eva-Katrine Aarnes; Malin F Forsberg; Gunnar B Kristensen; Renske Dm Steenbergen; Heidi Lyng
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

Review 3.  What gastric cancer proteomic studies show about gastric carcinogenesis?

Authors:  Mariana Ferreira Leal; Fernanda Wisnieski; Carolina de Oliveira Gigek; Leonardo Caires do Santos; Danielle Queiroz Calcagno; Rommel Rodriguez Burbano; Marilia Cardoso Smith
Journal:  Tumour Biol       Date:  2016-04-28

4.  Effect of RNA Interference Inhibiting the Expression of the FUBP1 Gene on Biological Function of Gastric Cancer Cell Line SGC7901.

Authors:  Fucheng Zhang; Yingge Zhang; Yaojun Wang
Journal:  Turk J Gastroenterol       Date:  2021-11       Impact factor: 1.852

5.  Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.

Authors:  Patricia Martin-Romano; Jose J Sola; Juan A Diaz-Gonzalez; Ana Chopitea; Yohana Iragorri; Fernando Martínez-Regueira; Mariano Ponz-Sarvise; Leire Arbea; Jose C Subtil; David Cano; Lucia Ceniceros; Jairo Legaspi; Jose Luis Hernandez; Javier Rodríguez
Journal:  Br J Cancer       Date:  2016-08-18       Impact factor: 7.640

Review 6.  Molecular predictive markers in tumors of the gastrointestinal tract.

Authors:  Eirini Papadopoulou; Vasiliki Metaxa-Mariatou; Georgios Tsaousis; Nikolaos Tsoulos; Angeliki Tsirigoti; Chrisoula Efstathiadou; Angela Apessos; Konstantinos Agiannitopoulos; Georgia Pepe; Eugenia Bourkoula; George Nasioulas
Journal:  World J Gastrointest Oncol       Date:  2016-11-15

7.  Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.

Authors:  Dongmei Fan; Baoqi Ren; Xiaojun Yang; Jia Liu; Zhengzheng Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-11-15

8.  Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer.

Authors:  So-Woon Kim; Jin Roh; Hye Seung Lee; Min-Hee Ryu; Young-Soo Park; Chan-Sik Park
Journal:  Gastric Cancer       Date:  2020-09-14       Impact factor: 7.370

9.  Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma.

Authors:  Selena Y Lin; Adam Zhang; Jessica Lian; Jeremy Wang; Ting-Tsung Chang; Yih-Jyh Lin; Wei Song; Ying-Hsiu Su
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

10.  Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.

Authors:  Li Xu; Liang Fengji; Liu Changning; Zhang Liangcai; Li Yinghui; Li Yu; Chen Shanguang; Xiong Jianghui
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.